SciELO - Scientific Electronic Library Online

 
vol.15 número2Caracterización de las inmunoglobulinas del ñandú (Rhea americana)Seroprevalencia y estudio de factores asociados a la neosporosis canina en animales ingresados al Hospital Escuela, FCV-UBA, Argentina índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

Compartir


InVet

versión On-line ISSN 1668-3498

Resumen

GOMEZ, N et al. Efficacy of a combination of two nucleoside and one non-nucleoside reverse transcriptase inhibitors in Feline Immunodeficiency Virus-naturally infected cats, during the last stages of the disease. InVet [online]. 2013, vol.15, n.2, pp.103-115. ISSN 1668-3498.

The aim of this study was to report the comparative results using combined antiviral drugs on naturally-infected FIV cats in the asymptomatic and AIDS stages of the disease. The drug combinations evaluated were zidovudine (ZDV) alone and ZDV + lamivudine (3TC) +Nevirapine. Plasma viral load was measured at the beginning of treatment and at one year. Total leucocytes, neutrophils and lymphocyte counts, CD4+/CD8+ ratios and biochemical profile values were also analyzed. Neurological disease was evaluated by evoked potentials determinations. The results showed a better efficacy of the combined therapy vs. ZDV alone, reducing the viral load, increasing the CD4+/CD8+ ratio and improving the clinical signs in the asymptomatic stage. In the AIDS stage the differences between both protocols were not so marked, but the combined therapy produced better results compared with ZDV alone. The auditory and visual evoked potentials put on evidence the neurological disease, even in cats without neurologic signs and were useful to evaluate the evolution of the patients with both protocols contrasted

Palabras clave : FIV; Antiretrovirals; Asymptomatic stage; AIDS stage; Zidovudine; Lamivudine; Nevirapine.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons